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New Concepts in Understanding 
the Pathophysiology of Chronic Pancreatitis 
To the Editor: 
The recently published paper entitled "New Con- 
cepts in Understanding the Pathophysiology of
Chronic Pancreatitis" by S. Freedman summarizes 
"the current research knowledge" on the patho- 
physiology of chronic pancreatitis (1). With respect 
to the formation of intraductal p ugs and pancreatic 
stones, we would like to comment on these concepts, 
since evidence from recent literature has not been 
incorporated. 
Two secretory pancreatic proteins have been iden- 
tified as components of intraductal plugs: pan- 
creatic stone protein (PSP) and GP-2, a membrane- 
anchored glycoprotein that is released into the juice 
during the secretion process. The presence of GP-2 
in plugs has been associated with an acidification 
of the centroacinar lumen. However, aggregate for- 
mation has not been achieved in vitro by simple acid- 
ification (1). PSP, reportedly the predominant protein 
component ofpancreatic plugs and stones (2-5), on 
the other hand, may be rendered insoluble through 
"partial activation of pancreatic zymogens within 
smaller ducts," since minimal amounts of active 
trypsin suffice to cleave PSP, thereby shortening the 
protein by 11 amino acids and leading to sponta- 
neous precipitation of the product (5). In our own 
work with recombinant rat PSP (6), we were able to 
reproduce this finding in vitro (7). In our view, PSP 
is still the best-documented protein component of 
pancreatic plugs or stones. 
Further in his paper, Freedman recapitulates the 
issue "pancreatic stones." There he selectively cites 
Mul-tigner et al.'s paper (8) on the capacity of PSP 
(="lithostathine") to prevent calcium carbonate pre- 
cipitation in vitro. However, the experimental basis 
ofthe"lithostathine hypothesis" was seriously ques- 
tioned by our own group in 1997 (9). The in vitro 
activity reported by Sarles' group according to our 
experiments, merely turned out to be a nonspecific 
effect of a protein at micromolar concentrations, an 
effect that PSP shared with many other randomly 
chosen proteins and furthermore with phosphate 
ions, thus an effect hat does not deserve to be called 
a functional activity. We therefore consider the 
"lithostathine hypothesis" unsupportable and the 
name "lithostathine" misleading. We have recently 
found support for our view in a paper published by 
DeReggi et al. (I0). Freedman mentions only the 
still unresolved controversy regarding PSP levels in 
pancreatic juice of different groups of patients, but 
fails to discuss that the function of PSP/reg has not 
been clarified, which makes interpretations of fluc- 
tuations in PSP levels highly speculative. 
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